MedTrace Logo

Pippa Pessary Study (Clinical Trial)

NCT05611970 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2026-03-13

Study results available
· View outcomes & findings →

Summary

This is an open label, interventional, single arm, multi-clinic study where each adult female participant with stress urinary incontinence (SUI) serves as her own control (vaginal pessary use vs. no vaginal pessary).

Conditions

  • Stress Urinary Incontinence

Interventions

DEVICE

Vaginal pessary

A reusable vaginal pessary for stress urinary incontinence

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Liv Labs Inc.

    lead INDUSTRY

Principal Investigators

  • Melody A Roberts · Liv Labs Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-13
Primary Completion
2024-04-09
Completion
2024-04-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05611970 on ClinicalTrials.gov